Historical Valuation
YD Bio Ltd (YDES) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of YD Bio Ltd (YDES) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：12.33
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
YD Bio Ltd (YDES) has a current Price-to-Book (P/B) ratio of 2.63. Compared to its 3-year average P/B ratio of 2.99 , the current P/B ratio is approximately -12.32% higher. Relative to its 5-year average P/B ratio of 2.99, the current P/B ratio is about -12.32% higher. YD Bio Ltd (YDES) has a Forward Free Cash Flow (FCF) yield of approximately -0.23%. Compared to its 3-year average FCF yield of -1.03%, the current FCF yield is approximately -78.09% lower. Relative to its 5-year average FCF yield of -1.03% , the current FCF yield is about -78.09% lower.
P/B
Median3y
2.99
Median5y
2.99
FCF Yield
Median3y
-1.03
Median5y
-1.03
Competitors Valuation Multiple
AI Analysis for YDES
The average P/S ratio for YDES competitors is 7.47, providing a benchmark for relative valuation. YD Bio Ltd Corp (YDES.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of 39.42%, this premium appears sustainable.
Performance Decomposition
AI Analysis for YDES
1Y
3Y
5Y
Market capitalization of YDES increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of YDES in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is YDES currently overvalued or undervalued?
YD Bio Ltd (YDES) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of YD Bio Ltd (YDES) is between to according to relative valuation methord.
What is YD Bio Ltd (YDES) fair value?
YDES's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of YD Bio Ltd (YDES) is between to according to relative valuation methord.
How does YDES's valuation metrics compare to the industry average?
The average P/S ratio for YDES's competitors is 7.47, providing a benchmark for relative valuation. YD Bio Ltd Corp (YDES) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 39.42%, this premium appears sustainable.
What is the current P/B ratio for YD Bio Ltd (YDES) as of Jan 09 2026?
As of Jan 09 2026, YD Bio Ltd (YDES) has a P/B ratio of 2.63. This indicates that the market values YDES at 2.63 times its book value.
What is the current FCF Yield for YD Bio Ltd (YDES) as of Jan 09 2026?
As of Jan 09 2026, YD Bio Ltd (YDES) has a FCF Yield of -0.23%. This means that for every dollar of YD Bio Ltd’s market capitalization, the company generates -0.23 cents in free cash flow.
What is the current Forward P/E ratio for YD Bio Ltd (YDES) as of Jan 09 2026?
As of Jan 09 2026, YD Bio Ltd (YDES) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of YD Bio Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for YD Bio Ltd (YDES) as of Jan 09 2026?
As of Jan 09 2026, YD Bio Ltd (YDES) has a Forward P/S ratio of 0.00. This means the market is valuing YDES at $0.00 for every dollar of expected revenue over the next 12 months.